Intense ADT tied to positive pathologic responses in prostate cancer
Intense neoadjuvant hormone therapy in high-risk localized prostate cancer is associated with favourable pathologic responses (tumour <5 mm) in nearly one of five patients, a phase II study has shown. In addition, pathologic responses are comparable between treatment groups.